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Abstract
Tendon/ligament injury or skin injuries due to diseases, trauma, and surgery are common. 
Timely functional repair and tissue regeneration is a key to improve the quality of life of 
the patient while reducing health care cost. Tendon/ligament/skin is also enriched in a 
common extracellular matrix (ECM), collagen I, III, and elastin. Tissue engineering and 
regenerative medicine, the combination of (stem) cells, growth factors, and biomaterial 
scaffolds, is an emergent field, which has attracted substantial attention over the years. 
Biomaterials are considered the foundation of regenerative medicine. A key to find a new 
solution to tendon/ligament/skin healing is to synthesize new functional biomaterials, 
which have better biomechanical properties, biodegradability, and cell supporting prop‐
erties. This chapter will review existing FDA‐approved biomaterial‐based therapy, as well 
as those in development.
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1. Introduction
From material science point of view, tendon/ligament and skin tissue are similar in that they 
are mainly composed of collagen and elastin. Up to 80% of the dry weight is collagen type I. 
However, their micro and hierarchical structures and functions are very different from each 
other. Tendon/ligament is composed of densely packed, aligned collagen fiber bundles, 
whereas skin is composed of a layered structure of collagen random naonfibril network. Table 1 
 summarizes the key properties of tendon/ligament and skin tissue in human.
The regeneration of a large size, lost tendon/ligament, and skin tissue normally involves a 
type of stem cells/progenitor cells of endogenous origin or exogenous origin combined with a 
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 biomaterial. Stem cells can be derived from tendon/ligament or skin, or from embryo, pla‐
centa, adipose tissue, bone marrow, umbilical cord, etc. This review focuses only on regenera‐
tion using exogenous stem cells coupled with a biomaterial matrix/carrier implanted to the 
wound site. Biomaterial can play a key role in protection of the cells from dehydration while 
it serves as a temporary substrate for stem cells to proliferate, or differentiate, and synthesize 
tissue‐specific matrix. The morphology, topography, composition, stiffness of biomaterials 
may play a key role in controlling the differentiation of stem cells, in addition to biochemical 
factors, mechanical cues, or genetic/cellular cues. This chapter focuses on biomaterial explored 
for tendon/ligament/skin tissue regeneration applications.
1.1. Research methods
We performed a comprehensive search of PubMed using keywords “tendon,” “ligament,” 
“skin,” “regeneration,” “scaffold”, over the years 1970–2016. All articles relevant to the subject 
were retrieved, and their bibliographies hand searched for further references in the context to 
biomaterials for tendon/ligament/skin regeneration
2. Results
2.1. Biomaterial directly derived from patients
2.1.1. PRP
Platelet‐rich plasma (PRP) is derived from blood and PRP gel is widely used for tendon/
ligament repair. Recently, PRP was combined with adipose‐derived stem cells (ADSCs) and 
it was found that PRP combined with stem cells resulted in improved mechanical strength 
in a rabbit tendon model compared to PRP gel alone [1]. Similar results were also observed 
using PRP with tendon‐derived stem cells (TDSCs) [2]. However, in a sheep model, no differ‐
ences were observed between the PRP group and PRP‐stem cell group [3]. This approach is 
highly translational, since both autologous stem cells and PRP can be obtained from the same 
patients. The concern may be the leucocytes‐containing PRP (L‐PRP) that have a  catabolic 
Tendon/ligament Skin
Main composition >80% Collagen, ∼5% elastin elastin >80% Collagen, ∼5% elastin
Minor composition Fibronectin, proteoglycan Fibronectin, proteoglycan
Main cells Fibroblast Fibroblast and keratinocytes
Vasculature Few Abundant
Structure 1D Aligned fiber bundles (nano‐macro) 2D random nanofibrils (weave basket 
pattern)
Mechanical properties Strong and elastic Weak and elastic
Table 1. A general comparison of two different connective tissues: tendon/ligament and skin.
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effect, whereas pure PRP (P‐PRP) without leucocytes have anabolic effects and results in over‐
proliferation and scar tissue formation. The complex interaction between PRP and stem cells 
may explain the different preclinical outcome and warrant a large random clinical trial.
2.1.2. Fibrin
Fibrin can be derived from human plasma. After addition of thrombin, it will form a gel, a 
process used for blood clotting. Stem cells can be added together with fibrin and thrombin and 
sprayed onto the wound for the promotion of wound closure and healing. The fibrin combined 
with bone marrow stem cells spray was successfully tested to prevent ulceration and acceler‐
ate wound closure in mice [4]. A small human clinical trial showed this approach accelerates 
wound closure and resurfacing without adverse effects [5]. Poly(ethylene glycol) PEG‐modified 
fibrin combined with adipose‐derived stem cells (ADSCs) also showed promising results in 
a pig burn model [6].
2.1.3. Amniotic membrane
Human placenta‐derived biomaterial is unique in that it has immune privilege while it con‐
tains multiple growth factors. Human ADSCs (hADSCs) seeded onto radiosterilized human 
amnion are viable and can proliferate. These cells are able to migrate over these scaffolds as 
demonstrated by using time‐lapse microscopy. In addition, the scaffolds induce hADSCs to 
secrete interleukin‐10, an important negative regulator of inflammation [7]. This suggests that 
placenta‐derived biomaterial may be a good substrate for stem cells and used for skin/tendon 
applications.
3D micronized (300–600 μm) amniotic membrane (mAM) was made by means of repeated 
freeze‐thawing cycles to deplete cell components and homogenized with a macrohomoge‐
nizer in liquid nitrogen. These mAM loaded with epidermal stem cells (ESCs) (ESC‐mAM) 
was further transplanted to full‐thickness skin defects in nude mice. ESCs survived well 
and formed a new epidermis. Four weeks after transplantation, papilla‐like structures were 
observed, and collagen fibers were well and regularly arranged in the newly formed dermal 
layer. In conclusion, the mAM as a novel natural microcarrier possesses an intact basement 
membrane structure and bioactivities [8].
2.2. FDA‐approved ECM grafts for tendon augmentation and skin regeneration
A recent study showed that decellularized matrix from different tissues (tendon, bone, and 
skin) affect the differentiation of stem cell in a different way. Decellularized bone matrix may 
induce the undesirable osteogenic differentiation of stem cells, while tendon or skin matrix 
does not have such an effect [9]. The ECM components provide a niche for proper differentia‐
tion of stem cells. For example, ECM without biglycan (Bgn) and fibromodulin (Fmod) will 
affect the differentiation of tendon stem cells by modulating bone morphogenetic protein 
signaling and impairs tendon formation in vivo [10]. Autologous origin, but decelluarized der‐
mal matrix using trypsin and Trion X‐100, after combined with ADSCs, was found to enhance 
wound healing in a murine model of a full‐thickness skin defect [11].
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Many FDA‐approved human or animal decelluarized tissue matrixes have been approved 
for direct tendon/ligament/skin repair without any (stem) cells (Table 2). The key advantages 
of decellularized tissue grafts are that they largely maintain the main architecture, composi‐
tion, and mechanical properties of native tissues. These allografts/xenografts are processed 
to remove immunogenic cells, DNAs, and certain immunogenic molecules. Typical problems 
are that these grafts are slower to repair the tissue and some fail to restore the proper func‐
tions (e.g., scarring). For tissue regeneration using these ECM biological grafts, stem cells 
may need to be reseeded onto the grafts for recellularization. For a dense tendon allograft, 
direct cell seeding may be difficult. The recellularization onto the surface may be achieved 
using a cell‐loaded gel coating [12]. However, it is highly desirable to get cells inside the 
grafts as well. Thus, ECM grafts may be processed to have a much higher porosity than 
the original tissue. Proration/incision into the ECM grafts may help the penetration of cells 
and nutrients. Instead of being coated with cell‐laden gel, an interesting approach is to use 
a stem cell‐sheet to wrap around a frozen tendon graft for implantation [13]. Interesting, a 
case report showed that a dermal allograft combined with PRP and autologous mesenchymal 
stem cells (MSCs) derived from peripheral blood (PB‐MSCs) resulted in enhanced healing of 
human rotator cuff [14].
Some of the FDA‐approved ECM biomatrices were combined with stem cells, and investigated 
for tendon/ligament/skin regeneration applications. Human acellular allograft (Alloderm) 
was investigated for direct cell seeding using ADSCs. It was concluded that human ADSCs can 
attach to Alloderm with the dermis side up in a petri dish [15]. ADSC seeded onto Alloderm 
was also implanted in vivo for skin regenerations with promising results [16]. Strattice was 
evaluated for seeding with rat MSCs [17]. Thus, the stem cell‐seeded biologic graft can be 
used as a tendon wrap or a skin regeneration material. A study was performed to compare the 
survival and proliferation of stem cells via bioluminescent imaging. The use of biologic graft 
Alloderm Human skin (decelluarized)
GraftJacket Human skin
Restore 10‐layered porcine small intestine
submucosa (SIS) treated with peracetic acid/ethanol (90% 
collagen, 5–10% lipids)
TissueMend Noncrosslinked fetal biovine dermal matrix [19]
BioBlanket Crosslinked porous bovine dermis
Permacol or Zimmer collagen repair patch Porcine acelluar dermis treated with trypsin, solvent, and 
crosslinked with hexamethylene diisocyanate (HMDI)
Strattice Porcine acelluar dermal matrix
Cuffpatch EDC‐crosslinked matrix from eight layers of treated SIS 
(97% collagen, 2% elastin)
OrthoADAPT Crosslinked equine pericardium (90% collagen I, 10% 
collagen II)
Table 2. An example list of biologic ECM grafts with potential for tendon/skin regeneration.
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patch (SIS) as carrier of ADSCs significantly increases the survival of stem cells as compared 
to direct injection of ADSCs into the skin wounds [18]. There may be a synergistic angiogen‐
esis promoting effects of biologic graft with stem cells, which may be important for tendon/
skin wound healing [19].
Another interesting approach is to use ECM directly secreted by the cells as a carrier for stem 
cells. For example, stem cells can be incubated at 37°C in a temperature‐responsive flask (e.g., 
upcellTM, Cellseed, Japan) and they will product ECM after addition of ascorbic acid. The cell 
sheets can be lifted at room temperature since the Poly‐n‐isopropylacrylamide (Poly‐NIPAM)‐
based substrate will become soluble at lower temperature. The cell‐ECM sheet has been explored 
for promotion of tendon/ligament healing [20] as well as diabetic skin wound healing [21].
2.3. FDA‐approved biomaterial
2.3.1. Collagen sponge scaffold
(5 mm × 2 mm) collagen sponge scaffolds (Zimmer Dental) were used for the culture of (BM) 
MSCs. Cell‐seeded scaffolds were placed in culture dishes and incubated for 2 hours in a 
minimum volume of growth medium, after which more medium was applied to submerge 
the scaffolds. After an additional 24‐hour culture, cells seeded in scaffolds were treated with 
10 ng/mL of recombinant (BMP) 12 for 12 hours. The medium was then replaced with fresh 
growth medium and scaffolds were either cultured for an additional 7 days or immediately 
implanted into partial calcaneal tendon defects in rats. It was shown that after 21 days, the 
BMP12‐treated, collagen‐cell scaffold results in robust formation of tendon‐like tissue [22]. 
Similarly, a collagen carrier combined with ASDCs showed they did not improve the biome‐
chanical properties of the tendon‐to‐bone healing. However, the ADSCs group showed less 
inflammation, which may lead to a more elastic repair and less scarred healing in a rat model.
2.3.2. Integra bilayer
Integra® bilayer wound Matrix (LifeSciences Corp., Plainsboro, New Jersey) is a dermal acellular 
analog composed of bovine collagen type I crosslinked with glycosaminoglycans. Importantly, 
inclusion of WJ‐MSC into Integra induced significant up‐regulation of prototypical angiogenic 
and healing factors, stimulating pleiotropic aspects of neovascularization in experimental set‐
tings of angiogenesis, without altering the inflammatory response in the animals, thus dem‐
onstrating their potential benefit in therapeutic care of wounds and skin grafts [23]. Recently, 
Integra dermal matrix scaffold engineered with adult mesenchymal stem cells and platelet‐rich 
plasma was investigated in vitro and demonstrated promising preliminary results [24].
2.4. Synthetic biopolymer matrix
Biopolymer matrix such as collagen, gelatin, hyaluronic acid, chitosan, silk, cellulose are the 
essential ECM components of human, animal, or plant cells. They have showed great promise 
for attachment, proliferation, and differentiation of stem cells and have been explored for 
tendon and skin regeneration.




Collagen monomer solution can be extracted from skin of fetal bovine calf in close herd. 
Collagen‐based biomaterial has been widely used for tendon/skin regeneration. For tendon 
application, it is highly desirable to prepare aligned collagen fiber scaffolds. Anisotropic col‐
lagen biomaterial can be prepared by directional freeze drying [25], electrospinning, or a 
novel process called electrochemical process. Electrochemically aligned collagen fiber and 
skin substrate have been coupled with stem cells for both tendon [26] and skin regeneration 
[27], respectively. Collagen carrier/gel [28] or collagen combined with stem cell accelerated 
the wound healing in healing‐impaired db/db mice [29].
2.4.2. Pullulan‐collagen hydrogel
A biomimetic pullulan‐collagen hydrogel was used to create a functional biomaterial‐based 
stem cell niche for the delivery of MSCs into wounds. Murine bone marrow‐derived MSCs 
were seeded into hydrogels and compared to MSCs grown in standard culture conditions. 
Hydrogels induced MSC secretion of angiogenic cytokines and expression of transcription 
factors associated with maintenance of pluripotency and self‐renewal. MSC‐seeded hydro‐
gels showed significantly accelerated healing and a return of skin appendages [30].
2.4.3. Gelatin
Gelatin is denatured collagen. Human ADSCs laden gelatin microcryogels (GMs) were evalu‐
ated in vitro as a stem cell carrier. The cell phenotype markers, stemness genes, differenti‐
ation, secretion of growth factors, cell apoptosis, and cell memory were compared against 
cells without a carrier. The priming effects of GMs on upregulation of stemness genes and 
improved secretion of growth factors of hASCs were demonstrated.
2.4.4. Hyaluronic acid (HA)
Hyaluronic acid (HA) is a nonsulfated, linear polysaccharide with the repeating disaccharide, 
β‐1,4‐D‐glucuronic acid ‐ β‐1,3‐N‐acetyl‐D‐glucosamine (Mw: 100–8000 KDa). It is an ECM 
component. ADSCs combined with hyaluronic acid (ADSC‐HA) dermal filler were implanted 
in rats and compared with HA alone. It was demonstrated that ADSC‐HA has better filling 
effects than HA alone. A total of 70% of stem cells remain in the injection site after 3 months. 
These suggested stem cells have the potential to improve the esthetic effects and longevity of 
dermal fillers [31].
2.4.5. Chitin/Chitosan
Chitosan‐hyaluron membrane: Hsu et al. investigated adult ADSCs spheroids combined with 
a chitosan‐hyaluron membrane and showed biomaterial combined with stem cells promoted 
wound healing in a rat skin repair model [32]. Dense and porous chitosan‐xanthan mem‐
branes seeded with multipotent mesenchymal stromal cells were evaluated for the treatment 
of skin wounds. The membranes showed to be nonmutagenic and allowed efficient adhesion 
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and proliferation of the mesenchymal stromal cells in vitro. In vivo assays performed with 
mesenchymal stromal cells grown on the surface of the dense membranes showed accelera‐
tion of wound healing in Wistar rats [33].
2.4.6. Gelatin/PEG
A thiol‐ene Michael‐type addition was utilized for rapid encapsulation of MSCs within a gela‐
tin/PEG biomatrix according to Eq. (1). The MSCs/gelatin/PEG biomatrix was applied as a 
provisional dressing to full‐thickness wounds in Sprague‐Dawley rats. Biomatrix resulted in 
attenuated immune cell infiltration, lack of foreign giant cell (FBGC) formation, accelerated 
wound closure and re‐epithelialization, as well as enhanced neovascularization and granula‐
tion tissue formation by 7 days [34].
  Gelatin ‐ PEG ‐ SH + PEG‐diacrylate → Gelatin ‐ PEG hydrogel (1)
2.4.7. Silk
Electrospun nanofiberous scaffolds prepared from silk fibroin protein were seeded with bone 
marrow‐derived mesenchymal stem cells (MSCs) and epidermal stem cells (ESCs). The con‐
structs were evaluated for wound re‐epithelization, collagen synthesis, as well as the skin 
appendages regeneration. It was shown that both the transplantation of MSCs and ESCs could 
significantly accelerate the skin re‐epithelization, stimulate the collagen synthesis. Furthermore, 
the regenerative features of MSCs and ESCs in activating the blood vessels and hair follicles for‐
mation, respectively, were suggested [35]. Combination of silk with collagen or poly(lactic‐co‐
glycolic acid) (PLGA) [18] and stem cells were evaluated in a rabbit tendon defect model [36].
2.4.8. Fibrin‐agarose
A stroma skin substitute was first generated by using a mixture of human fibrin obtained 
from frozen human plasma and 0.1% agarose. An average of 250,000 cultured skin fibro‐
blasts were added to 5 mL of the mixture immediately before inducing the polymerization 
of the artificial stroma on Transwell (Corning Enterprises, Corning, NY, http://www.corning.
com) porous inserts. Once the stromas jellified, human umbilical cord Wharton’s jelly stem 
cells (HWJSCs) were seeded on top of the skin artificial stromas and cultured. It was demon‐
strated that this 3D bioactive scaffold can stratify and form epithelial cell‐like layers and well‐
formed cell‐cell junctions [37]. The authors also demonstrated similar strategy can be used 
for regeneration of oral mucosa using human Wharton’s jelly stem cells (HWJSCs)‐seeded 
fibrin‐agarose‐mucosal fibroblasts.
2.4.9. Sodium carboxymethylcellulose (CMC)
Sodium CMC was evaluated as a substrate for ADSCs and implanted in adult male Wistar 
rats. CMC at 10 mg/mL associated with ADSCs increased the rate of cell proliferation of the 
granulation tissue and epithelium thickness when compared to untreated lesions (Sham). 
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CMC is capable to allow the growth of ADSCs and is safe for this biological application up to 
the concentration of 20 mg/mL. These findings suggest that CMC is a promising biomaterial 
to be used in cell therapy [38].
2.5. Synthetic nondegradable polymer‐based biomaterial
Table 3 summarizes common nondegradable polymer used as a biomaterial or as a modifier of 
ECM‐based biopolymer for skin and tendon tissue engineering applications. The incorporation 
of such polymer allows biopolymer (collagen, gelatin, HA) to be able to gelled at physiological 
condition (e.g., under UV/blue light, ambient temperature, or room temperature aqueous free 
radical initiator. Stem cells can be directly encapsulated inside the substrate during gel formation.
2.5.1. Poly(NIPAM)‐based
A biodegradable, multifunctional crosslinker and an n‐isopropylacrylamide (NIPAM)‐based, 
thermosensitive hydrogel was synthesized to carry BMSCs to treat diabetic skin ulcers. The 
crosslinker contains an arginylglycylaspartic acid(GRD)‐like motif that promotes cell attach‐
ment and differentiation of BMSCs. After hydrogel association with BMSCs treated the 
diabetic skin wound in mice, significantly greater wound contraction was observed in the 
hydrogel + BMSCs group. Histology and immunohistochemistry results confirmed that this 
treatment contributed to the rapid healing of diabetic skin wounds by promoting granulation 
tissue formation, angiogenesis, extracellular matrix (ECM) secretion, wound contraction, and 
re‐epithelialization. These results show that a hydrogel laden with BMSCs may be a promis‐
ing therapeutic strategy for the management of diabetic ulcers [39].
2.6. Polyester‐based degradable polymer biomaterial
The structure of common polyester is shown in Table 4. Stem cell‐coated polyester suture was 
evaluated for tendon applications in a rat model [40]. Electrospun PLGA fiber may be more suit‐
able for tendon regeneration than film [41]. (PGA/PLA) fiber combined with ADSCs improve 
tendon in a rabbit tendon model [42]. Open cell PLGA seeded with stem cells produced more 
collagen type I [43]. Knited PLGA encapsulated with stem cell/alginate gel [44]. PGA sheet with 
MSCs were able to regenerate tendon‐bone insertions and the tendon in rabbit [45]. Electrospun 
polycaprolactone/gelatin (PCL/GT) membrane and human urine‐derived stem cells (USCs) 
were evaluated for skin wound healing in a rabbit model [46]. USCs‐PCL/GT‐treated 
wounds closed much faster, with increased re‐epithelialization, collagen formation, and 
Poly(NIPAM) PEGDA Poly(methyl acrylate) (PMA)
Table 3. Common synthetic, nondegradable polymer used as hydrogel or gel components.
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angiogenesis. Moreover, USCs could secrete vascular endothelial growth factor(VEGF) and 
transforming growth factor (TGF)‐β1, and USC‐conditioned medium enhanced the migra‐
tion, proliferation, and tube formation of endothelial cells. This data suggested that USCs in 
combination with PCL/GT significantly prompted the healing of full‐thickness skin wounds 
in rabbits. Similarly, electrospun poly (L‐lactide‐co‐ε‐caprolactone)/poloxamer (PLCL/P123) 
scaffolds combined with ADSCs enhanced skin wound healing in a rat model [47]. Chitosan‐
crosslinked poly (3‐hydroxybutyrate‐co‐3‐hydroxyvalerate) (PHBV) was used to load unre‐
stricted somatic stem cells. The cell‐laden scaffold showed better results during the healing 
process of skin defects in rat models [48, 49].
3. Conclusion
Biomaterials play an important role for attachment, survival, and function of stem cells. Many 
biomaterials are either used alone or as one component of the product for the regeneration of 
tendon/ligament/skin. Despite abundance of biomaterial developed, the optimal biomaterials 
that meet the structural, mechanical, functional requirement of tendon/ligament tissues to be 
regenerated remain a challenge. Novel biomaterial fabrication process, biomaterial design, 
and biomaterial synthesis toward tendon/ligament and skin regeneration are urgently needed.
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